Journal
WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE
Volume 7, Issue 2, Pages 258-264Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/wjtcm.wjtcm_55_20
Keywords
Chinese medical research; coronavirus disease 2019; severe acute respiratory syndrome coronavirus 2; virus-like particles
Categories
Funding
- Funding Program for Key Projects for International Cooperation on Science, Technology and Innovation [2020 YFE0205100]
- Fundamental Scientific Research of Central Public Welfare Foundation from China Academy of China Medical Sciences [YZ-202012]
Ask authors/readers for more resources
The global outbreak of COVID-19 has had disastrous consequences, with no approved medications currently available. The benefits of traditional Chinese medicine in combating the virus have been observed, and the use of virus-like particle models provides a safe and effective method for Chinese medicine in preventing and controlling newly identified infectious diseases.
Background: The global outbreak of coronavirus disease 2019 (COVID-19) has brought disastrous consequences to public health and medical systems, whereas no approved medications are currently available. Benefits of traditional Chinese medicine (TCM) against COVID -19 have been observed, however, the underlying mechanistic actions remain unclarified. Due to high pathogenicity and infectivity of the new coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), the lack of access to SARS-CoV-2 and biosafety level 3 (P3) facilities has impeded scientific investigations of TCM against COVID-19. Though low-pathogenic coronavirus and pseudoviral systems have been applied to substitute SARS-CoV-2 in fundamental studies, both models cannot imitate virological and clinical features associated with SARS-CoV-2. The virus -like particle (VLP) is a virological model that is safe and could be performed without biosafety protections. Aims and Objectives: To construct VLP of SARS-CoV-2 containing structural proteins of authentic viruses and resembling the morphology, partial life cycle, and immunoreactions of natural virions, and to introduce VLP into Chinese medical research. Materials and Methods: Using mammalian expression system, we have currently constructed SARS-CoV-2 VLP containing four essential structural proteins. Results: Based on this model, we propose six aspects of research that could be carried out for TCM formulas in the fight against COVID-19. Conclusion: Application of the VLP model provides a safe methodology to strengthen the response systems of Chinese medicine in preventing and controlling newly identified infectious diseases and offers collaborative opportunities for interdisciplinary deciphering of molecular and biological basis of anti-viral TCM formulas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available